Next Article in Journal
The Value of Magnetic Resonance Diffusion-Weighted Imaging and Dynamic Contrast Enhancement in the Diagnosis and Prognosis of Treatment Response in Patients with Epithelial Serous Ovarian Cancer
Next Article in Special Issue
Near-Infrared Fluorescence Axillary Reverse Mapping (ARM) Procedure in Invasive Breast Cancer: Relationship between Fluorescence Signal in ARM Lymph Nodes and Clinical Outcomes
Previous Article in Journal
Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View
Previous Article in Special Issue
Correlation between Colon Perfusion and Postoperative Fecal Output through a Transanal Drainage Tube during Laparoscopic Low Anterior Resection
 
 
Article
Peer-Review Record

Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett’s Esophagus

Cancers 2022, 14(10), 2462; https://doi.org/10.3390/cancers14102462
by Xiaojuan Zhao 1,2,†, Ruben Y. Gabriëls 1,†, Wouter T. R. Hooghiemstra 1,3, Marjory Koller 4, Gert Jan Meersma 1,2, Manon Buist-Homan 1,5, Lydia Visser 6, Dominic J. Robinson 7, Anna Tenditnaya 8,9, Dimitris Gorpas 8,9, Vasilis Ntziachristos 8,9, Arend Karrenbeld 6, Gursah Kats-Ugurlu 6, Rudolf S. N. Fehrmann 2 and Wouter B. Nagengast 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Cancers 2022, 14(10), 2462; https://doi.org/10.3390/cancers14102462
Submission received: 6 April 2022 / Revised: 6 May 2022 / Accepted: 13 May 2022 / Published: 17 May 2022

Round 1

Reviewer 1 Report

The paper by Zhao et al is an ambitious attempt to put together many results of both literature search and practical experimental work, including development of novel labeled markers. All in all, the paper is clear, well written and interesting. However, the huge amount of different data makes the paper a bit hard to penetrate and get a clear overview of the scope and message. I suggest removing Table 1 and 2 as well as Figure 1 and Figure S2 and mention as data not shown.

I also would like to see a much more extensive part in the introduction describing the protein/mRNA markers and the reason for that work, as well as the aim with the labeling. Also, references are very few in that part.

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

I thank the Editor for submitting this work to me for review.
The topic is interesting and useful but there are some inaccuracies in the definitions and in the structuring of the paper.

Introduction needs more precision in definitions. There is a bit of confusion in the description of materials and methods: sometimes Authors talk about genes, sometimes about mRNA and sometimes about proteins. It should be better described what is being studied and with what method (transcripts for mRNA, IHC for proteins, NGS for genes). The definitions of Barrett's esophagus, dysplasia and Barrett's adenocarcinoma are incorrect.
The pT classifications according to WHO and UICC 2017 are not correct.
The methodology of researching data in Literature is not clear.
The method of studying mucosectomies is unclear.

Finally, please review the annotations in the attached file.

Comments for author File: Comments.pdf

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

The paper has been improved.

Back to TopTop